Hrt Financial LP Co Diagnostics, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.39 - $3.24 $903 - $2,106	650 Added 5.48%	12,517 $18,000
Q4 2022 Feb 10, 2023	BUY	$2.32 - $3.68 $27,531 - $43,670	11,867 New	11,867 $29,000
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $142,927 - $273,068	-28,415 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $186,077 - $237,638	-22,916 Reduced 44.64%	28,415 $253,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $193,941 - $295,060	-25,928 Reduced 33.56%	51,331 $499,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $553,174 - $738,596	77,259 New	77,259 $637,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.